Hikma Beats GSK, Pfizer In Argatroban IP Infringement Row
GlaxoSmithKline PLC and Pfizer Inc. on Tuesday failed to stop Hikma Pharmaceutical Co. Ltd. from selling a generic version of anti-coagulant Argatroban after a New Jersey federal judge ruled the company...To view the full article, register now.
Already a subscriber? Click here to view full article